By Education & Outreach
AARP's Rx Watchdog newsletter highlights trends in the prescription drug market place and how those trends impact consumers.
It monitors the pricing, legislative, and public policies of the world's pharmaceutical manufacturers, and reports those policies, detrimental or beneficial, to AARP members and the American public.
Table of Contents
- "New Doughnut Hole Calculator Steers Part D Enrollees to Less Expensive Medications": Learn about AARP's new Doughnut Hole Calculator, available at no cost.
Read this entire Rx Watchdog newsletter issue online now.
More on the Doughnut Hole Calculator:
Table of Contents
- Making the Case for the Access to Life-Saving Medicine Act...1
- The EU: a Global Leader on Biosimilars...1
- What are Biologic, Generic and Biosimilar Drugs?...3
- Legal Front News Exclusion Payments: The Biggest Losers–Consumers...3
- Would Generic Biosimilars Keep Manufacturers From Recouping Their R&D Costs?..4
- AARP Federal Advocacy..4
- AARP State Advocacy...5
- From Personal Experience: Bonnie Cramer, Board Chair, AARP Board of Directors...5
- Did You know?...5
- The Tier 4 Phenomenon...6
Read the entire May 2009 issue online now.
Visit our "Rx Drug Smarts" site area for information on drug safety, medication errors, personal medication records, drug-label information, comparing drug effectiveness, and more.